Yehia I Mohamed

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Metastatic Colorectal Cancer

Angiotensin Converting Enzyme

Ejection Fraction

Top Venues

Journal of hepatocellular carcinoma

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Shadi Chamseddine, Michael LaPelusa, Lianchun Xiao, Yehia I Mohamed, Sunyoung S Lee, Zishuo Ian Hu, Rikita I Hatia, Manal Hassan, James C Yao, Dan G Duda, Saumil Datar, Hesham M Amin, Ahmed O Kaseb
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Shadi Chamseddine, Michael LaPelusa, Lianchun Xiao, Yehia I Mohamed, Sunyoung S Lee, Zishuo Ian Hu, Rikita I Hatia, Manal Hassan, James C Yao, Dan G Duda, Saumil Datar, Hesham M Amin, Ahmed O Kaseb
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Shadi Chamseddine, Michael LaPelusa, Lianchun Xiao, Yehia I Mohamed, Sunyoung S Lee, Zishuo Ian Hu, Rikita I Hatia, Manal Hassan, James C Yao, Dan G Duda, Saumil Datar, Hesham M Amin, Ahmed O Kaseb
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Muhammad O Awiwi, Khaled M Elsayes, Yehia I Mohamed, Lina Altameemi, Migena Gjoni, Omayr Muhammad Irshad, Ahmed F Sayed Ahmed, Ahmad O Kaseb, Usama Salem
The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab. Journal of hepatocellular carcinoma 9 (2022)
Ahmed Omar Kaseb, S Cheenu Kappadath, Sunyoung S Lee, Kanwal Pratap Raghav, Yehia I Mohamed, Lianchun Xiao, Jeffrey S Morris, Chimela Ohaji, Rony Avritscher, Bruno C Odisio, Joshua Kuban, Mohamed E Abdelsalam, Beth Chasen, Khaled M Elsayes, Mohamed Elbanan, Robert A Wolff, James C Yao, Armeen Mahvash
A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 8 (2021)
Ahmed Omar Kaseb, Yehia I Mohamed, Alexandre E Malek, Issam I Raad, Lina Altameemi, Dan Li, Omar A Kaseb, Safa A Kaseb, Abdelhafez Selim, Qing Ma
The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection. Pathogens (Basel, Switzerland) 10 (3) (2021)
Betul Gok Yavuz, Elshad Hasanov, Sunyoung S Lee, Yehia I Mohamed, Michael A Curran, Eugene Jon Koay, Vittorio Cristini, Ahmed O Kaseb
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 8 (2021)